Tuesday, March 17, 2026

The Next Trillion-Dollar Bet: Korean Pharma Invests in Immuno-Oncology, Targeting a $1 Trillion Global Market

Cho Yong-joon outlines Dongkoo Bio's transformation into a global healthcare leader, emphasizing convergence and innovative growth strategies.

Navigating Tariff Refunds: Key Insights for 6,000 South Korean Companies After U.S. Supreme Court Ruling

Korean exporters face uncertainty over tariff refunds after the U.S. Supreme Court ruling, fearing retaliation from the Trump administration.

THE JUNKIE AUNT VS. THE PRINCESS : Why Kim Yo-jong Was Demoted To A “Secretary” To Make Way For 12-Year-Old Ju Ae

Kim Yo-jong's influence in North Korea's Workers' Party has surged, but experts see her role as supportive rather than a rival to Kim Jong Un's daughter.

Tag: Yuhan

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.